Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
Epstein, Judith E
Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. [electronic resource] - Vaccine Apr 2004 - 1592-603 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
0264-410X
10.1016/j.vaccine.2004.01.031 doi
Adolescent
Adult
Animals
Antibodies, Protozoan--analysis
B-Lymphocytes--immunology
Female
Hepatitis B Antibodies--biosynthesis
Hepatitis B Surface Antigens--immunology
Humans
Immunization Schedule
Malaria Vaccines--adverse effects
Male
Plasmodium falciparum--immunology
Spores, Protozoan--immunology
T-Lymphocytes--immunology
Vaccines, DNA--adverse effects
Vaccines, Synthetic--adverse effects
Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. [electronic resource] - Vaccine Apr 2004 - 1592-603 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
0264-410X
10.1016/j.vaccine.2004.01.031 doi
Adolescent
Adult
Animals
Antibodies, Protozoan--analysis
B-Lymphocytes--immunology
Female
Hepatitis B Antibodies--biosynthesis
Hepatitis B Surface Antigens--immunology
Humans
Immunization Schedule
Malaria Vaccines--adverse effects
Male
Plasmodium falciparum--immunology
Spores, Protozoan--immunology
T-Lymphocytes--immunology
Vaccines, DNA--adverse effects
Vaccines, Synthetic--adverse effects